Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Certificates

Data access

Data access restrictions

Database access

Database licenses

Data licenses

Data upload

Data upload restrictions

Enhanced publication

Institution responsibility type

Institution type

Keywords

Metadata standards

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 4 result(s)
The Research Collection is ETH Zurich's publication platform. It unites the functions of a university bibliography, an open access repository and a research data repository within one platform. Researchers who are affiliated with ETH Zurich, the Swiss Federal Institute of Technology, may deposit research data from all domains. They can publish data as a standalone publication, publish it as supplementary material for an article, dissertation or another text, share it with colleagues or a research group, or deposit it for archiving purposes. Research-data-specific features include flexible access rights settings, DOI registration and a DOI preview workflow, content previews for zip- and tar-containers, as well as download statistics and altmetrics for published data. All data uploaded to the Research Collection are also transferred to the ETH Data Archive, ETH Zurich’s long-term archive.
Country
DataverseNO (https://dataverse.no) is a curated, FAIR-aligned national generic repository for open research data from all academic disciplines. DataverseNO commits to facilitate that published data remain accessible and (re)usable in a long-term perspective. The repository is owned and operated by UiT The Arctic University of Norway. DataverseNO accepts submissions from researchers primarily from Norwegian research institutions. Datasets in DataverseNO are grouped into institutional collections as well as special collections. The technical infrastructure of the repository is based on the open source application Dataverse (https://dataverse.org), which is developed by an international developer and user community led by Harvard University.
Country
Strasbourg astronomical Data Center (CDS) is dedicated to the collection and worldwide distribution of astronomical data and related information. Alongside data curation and service maintenance responsibilities, the CDS undertakes R&D activities that are fundamental to ensure the long term sustainability in a domain in which technology evolves very quickly. R&D areas include informatics, big data, and development of the astronomical Virtual Observatory (VO). CDS is a major actor in the VO with leading roles in European VO projects, the French Virtual Observatory and the International Virtual Observatory Alliance (IVOA). The CDS hosts the SIMBAD astronomical database, the world reference database for the identification of astronomical objects; VizieR, the catalogue service for the CDS reference collection of astronomical catalogues and tables published in academic journals; and the Aladin interactive software sky atlas for access, visualization and analysis of astronomical images, surveys, catalogues, databases and related data.
ChEMBL is a database of bioactive drug-like small molecules, it contains 2-D structures, calculated properties (e.g. logP, Molecular Weight, Lipinski Parameters, etc.) and abstracted bioactivities (e.g. binding constants, pharmacology and ADMET data). The data is abstracted and curated from the primary scientific literature, and cover a significant fraction of the SAR and discovery of modern drugs We attempt to normalise the bioactivities into a uniform set of end-points and units where possible, and also to tag the links between a molecular target and a published assay with a set of varying confidence levels. Additional data on clinical progress of compounds is being integrated into ChEMBL at the current time.